glycyrrhizic acid has been researched along with sorafenib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cao, R; Chamberlain, P; Cheah, JH; Collins, J; Esfandiary, T; Gardner, A; Hayward, AM; Hess, K; Ishida, K; Kirtane, AR; L'Heureux, J; Langer, R; Leboeuf, D; Lopes, A; Lytton-Jean, A; Navamajiti, N; Reker, D; Rogner, J; Rybakova, Y; Smekalova, EM; Soule, CK; Tamang, SM; Traverso, G; von Erlach, T; Yang, JW; Yun, D; Zhang, RM | 1 |
1 other study(ies) available for glycyrrhizic acid and sorafenib
Article | Year |
---|---|
Computationally guided high-throughput design of self-assembling drug nanoparticles.
Topics: Animals; Candida albicans; Computer Simulation; Drug Carriers; Drug Design; Drug Evaluation, Preclinical; Dynamic Light Scattering; Excipients; Female; Glycyrrhizic Acid; High-Throughput Screening Assays; Humans; Machine Learning; Mice, Inbred Strains; Nanoparticles; Skin Absorption; Sorafenib; Taurocholic Acid; Terbinafine; Tissue Distribution; Xenograft Model Antitumor Assays | 2021 |